Juergen debus
Juergen debus
Bestätigte E-Mail-Adresse bei med.uni-heidelberg.de
Zitiert von
Zitiert von
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma
A Engert, A Plütschow, HT Eich, A Lohri, B Dörken, P Borchmann, ...
New England Journal of Medicine 363 (7), 640-652, 2010
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
A Afshar-Oromieh, E Avtzi, FL Giesel, T Holland-Letz, HG Linhart, M Eder, ...
European journal of nuclear medicine and molecular imaging 42 (2), 197-209, 2015
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
A Afshar-Oromieh, CM Zechmann, A Malcher, M Eder, M Eisenhut, ...
European journal of nuclear medicine and molecular imaging 41 (1), 11-20, 2014
DNA methylation-based classification of central nervous system tumours
D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ...
Nature 555 (7697), 469-474, 2018
Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial
KK Herfarth, J Debus, F Lohr, ML Bahner, B Rhein, P Fritz, A Höss, ...
Journal of Clinical Oncology 19 (1), 164-170, 2001
Endostatin's antiangiogenic signaling network
A Abdollahi, P Hahnfeldt, C Maercker, HJ Gröne, J Debus, W Ansorge, ...
Molecular cell 13 (5), 649-663, 2004
Radiation oncology in the era of precision medicine
M Baumann, M Krause, J Overgaard, J Debus, SM Bentzen, J Daartz, ...
Nature Reviews Cancer 16 (4), 234, 2016
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group …
HT Eich, V Diehl, H Görgen, T Pabst, J Markova, J Debus, A Ho, B Dörken, ...
Journal of clinical oncology 28 (27), 4199-4206, 2010
Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases.
A Pirzkall, J Debus, F Lohr, M Fuss, B Rhein, R Engenhart-Cabillic, ...
Journal of Clinical Oncology 16 (11), 3563-3569, 1998
A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery
PE Huber, JW Jenne, R Rastert, I Simiantonakis, HP Sinn, HJ Strittmatter, ...
Cancer research 61 (23), 8441-8447, 2001
Results of carbon ion radiotherapy in 152 patients
D Schulz-Ertner, A Nikoghosyan, C Thilmann, T Haberer, O Jäkel, ...
International journal of radiation oncology* biology* physics 58 (2), 631-640, 2004
Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience
T Kamada, H Tsujii, EA Blakely, J Debus, W De Neve, M Durante, O Jäkel, ...
The Lancet Oncology 16 (2), e93-e100, 2015
Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution
SE Combs, C Thilmann, L Edler, J Debus, D Schulz-Ertner
Journal of clinical oncology 23 (34), 8863-8869, 2005
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
A Afshar-Oromieh, T Holland-Letz, FL Giesel, C Kratochwil, W Mier, ...
European journal of nuclear medicine and molecular imaging 44 (8), 1258-1268, 2017
Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas
D Schulz-Ertner, CP Karger, A Feuerhake, A Nikoghosyan, SE Combs, ...
International Journal of Radiation Oncology* Biology* Physics 68 (2), 449-457, 2007
PET imaging of somatostatin receptors using [68GA] DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas
M Henze, J Schuhmacher, P Hipp, J Kowalski, DW Becker, J Doll, ...
Journal of Nuclear Medicine 42 (7), 1053-1056, 2001
Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
CM Zechmann, A Afshar-Oromieh, T Armor, JB Stubbs, W Mier, ...
European journal of nuclear medicine and molecular imaging 41 (7), 1280-1292, 2014
Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors
MA Weber, S Zoubaa, M Schlieter, E Jüttler, HB Huttner, K Geletneky, ...
Neurology 66 (12), 1899-1906, 2006
Inhibition of αvβ3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy
A Abdollahi, DW Griggs, H Zieher, A Roth, KE Lipson, R Saffrich, ...
Clinical cancer research 11 (17), 6270-6279, 2005
High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results
J Debus, M Wuendrich, A Pirzkall, A Hoess, W Schlegel, I Zuna, ...
Journal of clinical oncology 19 (15), 3547-3553, 2001
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20